Shares of Roth Ch Acquisition V Co. (NASDAQ:ROCL – Get Rating) rose 0.2% on Tuesday . The company traded as high as $10.35 and last traded at $10.35. Approximately 513 shares traded hands during trading, a decline of 99% from the average daily volume of 54,580 shares. The stock had previously closed at $10.33.
Roth Ch Acquisition V Stock Performance
The business's 50-day moving average price is $10.27 and its two-hundred day moving average price is $10.13.
Get Roth Ch Acquisition V alerts:Hedge Funds Weigh In On Roth Ch Acquisition V
A number of hedge funds have recently added to or reduced their stakes in the business. Deltec Asset Management LLC acquired a new position in shares of Roth Ch Acquisition V during the first quarter valued at $1,032,000. Shaolin Capital Management LLC raised its stake in shares of Roth Ch Acquisition V by 14.0% during the fourth quarter. Shaolin Capital Management LLC now owns 812,400 shares of the company's stock valued at $8,213,000 after purchasing an additional 100,000 shares in the last quarter. Dark Forest Capital Management LP bought a new stake in shares of Roth Ch Acquisition V during the fourth quarter valued at about $88,000. RPO LLC bought a new stake in shares of Roth Ch Acquisition V during the fourth quarter valued at about $429,000. Finally, Elequin Securities LLC raised its stake in shares of Roth Ch Acquisition V by 6,250.0% during the fourth quarter. Elequin Securities LLC now owns 50,800 shares of the company's stock valued at $514,000 after purchasing an additional 50,000 shares in the last quarter.
Roth Ch Acquisition V Company Profile
(Get Rating)
Roth Ch Acquisition V Co does not have significant operations. The company focuses on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or related business combination with one or more businesses. It intends to identify business opportunities in the field of business services, consumer, healthcare, technology, wellness, and sustainability sectors.
Featured Stories
- Get a free copy of the StockNews.com research report on Roth Ch Acquisition V (ROCL)
- Gamida Cell Stock Jumps Over 100% on FDA Approval
- Insiders Buy EasyJet, Regularly And Repeatedly
- Bank of America Beats Earnings, Renews Investor Upside Potential
- The Analysts See A Bright Future For Sunrun
- J.B. Hunt: Economic Contraction And A Buying Opportunity
Receive News & Ratings for Roth Ch Acquisition V Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Roth Ch Acquisition V and related companies with MarketBeat.com's FREE daily email newsletter.